Find information on segmental pulmonary embolism diagnosis, including clinical documentation requirements, ICD-10 coding (I26), and healthcare guidelines. Learn about symptoms, risk factors, diagnostic testing (CTPA, VQ scan), and treatment options for segmental PE. This resource provides essential information for physicians, nurses, coders, and other healthcare professionals involved in the diagnosis and management of segmental pulmonary emboli.
Also known as
Pulmonary embolism
Blockage of an artery in the lungs.
Other pulmonary vascular disorders
Conditions affecting blood flow in the lungs, excluding embolism.
Diseases of veins, lymphatic vessels
Disorders affecting veins and lymphatic vessels, potentially contributing to embolism.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the pulmonary embolism segmental?
When to use each related code
| Description |
|---|
| Segmental Pulmonary Embolism |
| Subsegmental Pulmonary Embolism |
| Pulmonary Embolism, unspecified site |
Lack of documentation specifying the affected segmental artery branch leads to coding ambiguity and potential downcoding to a less specific PE code.
Insufficient documentation to differentiate between acute and chronic PE can cause inaccurate coding and affect reimbursement. CDI clarification is crucial.
Segmental PE involving the main pulmonary artery bifurcation can be mistakenly coded as a saddle PE, leading to overcoding and compliance issues.
Q: How to differentiate segmental pulmonary embolism from subsegmental pulmonary embolism in terms of management and prognosis?
A: Differentiating between segmental and subsegmental pulmonary embolism (PE) impacts management and prognosis. Segmental PE, involving a named segmental pulmonary artery, is often associated with a higher risk of adverse outcomes like recurrent venous thromboembolism or death compared to subsegmental PE, affecting smaller arteries. Current guidelines generally recommend anticoagulation for segmental PE. Subsegmental PE management is more nuanced, with decisions based on patient risk factors like active cancer, prior VTE, D-dimer levels, and alternative diagnoses. Consider implementing risk stratification tools such as the YEARS algorithm or the Wells score to help determine appropriate management for subsegmental PE. Explore how these tools can aid clinical decision-making in challenging PE cases. Further, recent research suggests the significance of subsegmental PE may have been historically underestimated and requires a comprehensive assessment of the individual patient context. Learn more about the evolving understanding of subsegmental PE management.
Q: What are the most effective diagnostic imaging protocols for confirming suspected segmental pulmonary embolism in a patient with renal insufficiency?
A: Diagnosing segmental pulmonary embolism (PE) in patients with renal insufficiency requires careful consideration of imaging modalities. CT pulmonary angiography (CTPA) is the gold standard for PE diagnosis but uses iodinated contrast, which poses a risk for contrast-induced nephropathy in those with renal impairment. In these patients, consider alternative or modified protocols. For example, a lower contrast dose CTPA, ventilation/perfusion (V/Q) scan, or magnetic resonance pulmonary angiography (MRPA) may be preferred. V/Q scanning avoids nephrotoxic contrast, but its sensitivity can be limited in patients with pre-existing lung disease. MRPA is another alternative, however, it can be less readily available and has longer acquisition times. Clinicians should carefully weigh the risks and benefits of each imaging modality in patients with renal insufficiency and choose the most appropriate protocol based on individual patient characteristics and institutional resources. Explore how these diagnostic strategies can ensure accurate PE detection while minimizing renal risks.
Patient presents with complaints suggestive of segmental pulmonary embolism. Symptoms include acute onset shortness of breath, pleuritic chest pain, and increased heart rate. Risk factors for pulmonary embolism, such as recent surgery, prolonged immobility, or history of deep vein thrombosis, were assessed. Physical examination revealed tachypnea and oxygen saturation below normal limits. D-dimer level was elevated. Computed tomography angiography of the chest demonstrated a filling defect within a segmental pulmonary artery, confirming the diagnosis of segmental pulmonary embolism. Differential diagnoses considered included pneumonia, myocardial infarction, and pleurisy. The patient was started on anticoagulation therapy with [Medication Name and Dosage]. Treatment plan includes monitoring for bleeding complications, assessing for right ventricular strain, and follow-up imaging as needed. Patient education provided regarding medication administration, signs and symptoms of complications, and importance of adherence to the treatment plan. ICD-10 code I26.9, pulmonary embolism unspecified, and CPT codes for the CTA chest and therapeutic procedures were documented for medical billing and coding purposes. Prognosis discussed with patient, and follow-up appointment scheduled. Plan to assess response to anticoagulation and evaluate for underlying thrombophilia if clinically indicated.